Resources

Filter By

Posters

Tau and Beyond: Proteomic Profiling of Neurodegenerative Diseases with a 120-Plex CNS Disease Panel

Download Poster

Development of NULISAseq Inflammation Panel 250 for Comprehensive Immune Profiling

Download Poster

Quantitative dissection of healthy aging using protein and peptide signatures from paired CSF and plasma

Poster presented at AAIC 2024

EMITT-1: Proof-of-mechanism immunopeptidome (ImPD) effects at target PK exposure, in a phase 1 study of GRWD5769 (a first-in-class inhibitor of Endoplasmic Reticulum Aminopeptidase 1 [ERAP1]) in patients with solid malignancies

Poster presented in collaboration with Grey Wolf Therapeutics at ASCO 2024 (Chicago, IL)

Synchronizing analysis with acquisition for significantly faster library free analysis of DIA

Poster presented at ASMS 2024, Anaheim (CA)

Cloud-based parallelization leads to a drastically faster library-free analysis in Spectronaut

Poster presented at ASMS 2024, Anaheim (CA)

Contact

Contact Form

Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland

Phone: +41 44 738 20 40

US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States

in

By Platforms & Applications

By Therapeutic Areas

By Research Phases

HIDDEN

Software

Kits

in

Resources

Posters

Tau and Beyond: Proteomic Profiling of Neurodegenerative Diseases with a 120-Plex CNS Disease Panel

Posters

Development of NULISAseq Inflammation Panel 250 for Comprehensive Immune Profiling

Posters

Quantitative dissection of healthy aging using protein and peptide signatures from paired CSF and plasma

Posters

EMITT-1: Proof-of-mechanism immunopeptidome (ImPD) effects at target PK exposure, in a phase 1 study of GRWD5769 (a first-in-class inhibitor of Endoplasmic Reticulum Aminopeptidase 1 [ERAP1]) in patients with solid malignancies

Posters

Synchronizing analysis with acquisition for significantly faster library free analysis of DIA

Posters

Cloud-based parallelization leads to a drastically faster library-free analysis in Spectronaut

Contact

New: Spectronaut^® 19

New: Spectronaut^® 19

Quick find

Follow us

By Platforms & Applications

By Therapeutic Areas

By Research Phases

HIDDEN

Software

Kits

in

Resources

Posters

Tau and Beyond: Proteomic Profiling of Neurodegenerative Diseases with a 120-Plex CNS Disease Panel

Posters

Development of NULISAseq Inflammation Panel 250 for Comprehensive Immune Profiling

Posters

Quantitative dissection of healthy aging using protein and peptide signatures from paired CSF and plasma

Posters

EMITT-1: Proof-of-mechanism immunopeptidome (ImPD) effects at target PK exposure, in a phase 1 study of GRWD5769 (a first-in-class inhibitor of Endoplasmic Reticulum Aminopeptidase 1 [ERAP1]) in patients with solid malignancies

Posters

Synchronizing analysis with acquisition for significantly faster library free analysis of DIA

Posters

Cloud-based parallelization leads to a drastically faster library-free analysis in Spectronaut

Contact

New: Spectronaut® 19

New: Spectronaut® 19

Quick find

Follow us

Newsletter

New: Spectronaut^® 19

New: Spectronaut^® 19